X4 Pharmaceuticals, Inc. ( XFOR) - Stock Earnings
XFOR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -29.8 million USD | 1.8 million USD |
| 2025Q4 | -23.9 million USD | 2.6 million USD |
| 2026Q1 | -20.2 million USD | 2.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
XFOR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -101.2 million USD | — USD |
| 2024 | -37.5 million USD | 2.6 million USD |
| 2025 | -79.2 million USD | 35.1 million USD |
| 2026 Est. | — | — |
XFOR
Price: $4.04
52 week price:
Earnings Per Share: -2.07 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 471700
Market Capitalization: 361.2 million